The Abl family kinases: mechanisms of regulation and signaling.

[1]  G. Superti-Furga,et al.  Autoinhibition of c-Abl , 2002, Cell.

[2]  M. Banerjee,et al.  Phosphorylation of Pak1 by the p35/Cdk5 Kinase Affects Neuronal Morphology* , 2001, The Journal of Biological Chemistry.

[3]  M. Peifer,et al.  Abelson kinase regulates epithelial morphogenesis in Drosophila , 2001, The Journal of cell biology.

[4]  T. Pawson,et al.  The Receptor Tyrosine Kinase EphB2 Regulates NMDA-Dependent Synaptic Function , 2001, Neuron.

[5]  A. Koleske,et al.  The Abl-related gene (Arg) nonreceptor tyrosine kinase uses two F-actin-binding domains to bundle F-actin , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[6]  G. Neubauer,et al.  Phosphorylation and structure-based functional studies reveal a positive and a negative role for the activation loop of the c-Abl tyrosine kinase , 2001, Oncogene.

[7]  R. A. Etten,et al.  Mutational analysis of the regulatory function of the c-Abl Src homology 3 domain , 2001, Oncogene.

[8]  A. Pendergast,et al.  Activated c-Abl is degraded by the ubiquitin-dependent proteasome pathway , 2001, Current Biology.

[9]  R. Fishel,et al.  BCR/ABL regulates mammalian RecA homologs, resulting in drug resistance. , 2001, Molecular cell.

[10]  Norbert Perrimon,et al.  Spatial control of the actin cytoskeleton in Drosophila epithelial cells , 2001, Nature Cell Biology.

[11]  N. Narula,et al.  Targeting of the c-Abl Tyrosine Kinase to Mitochondria in Endoplasmic Reticulum Stress-Induced Apoptosis , 2001, Molecular and Cellular Biology.

[12]  S. Goff,et al.  Inhibition of v-Abl transformation in 3T3 cells overexpressing different forms of the Abelson interactor protein Abi-1 , 2001, Oncogene.

[13]  M. Schwartz,et al.  c-Abl Tyrosine Kinase Binds and Phosphorylates Phospholipid Scramblase 1* , 2001, The Journal of Biological Chemistry.

[14]  T. Hunter,et al.  Inhibition of c-Abl Tyrosine Kinase Activity by Filamentous Actin* , 2001, The Journal of Biological Chemistry.

[15]  Bruce J Mayer,et al.  Regulation of Cbl phosphorylation by the Abl tyrosine kinase and the Nck SH2/SH3 adaptor , 2001, Oncogene.

[16]  E. Pasquale,et al.  Multiple signaling interactions of Abl and Arg kinases with the EphB2 receptor , 2001, Oncogene.

[17]  P. Vigneri,et al.  Tyrosine kinase inhibitor STI571 enhances thyroid cancer cell motile response to Hepatocyte Growth Factor , 2001, Oncogene.

[18]  M. Sudol,et al.  The β-Amyloid Precursor Protein APP Is Tyrosine-phosphorylated in Cells Expressing a Constitutively Active Form of the Abl Protoncogene* , 2001, The Journal of Biological Chemistry.

[19]  K. Rottner,et al.  The Abl interactor proteins localize to sites of actin polymerization at the tips of lamellipodia and filopodia , 2001, Current Biology.

[20]  R. Klemke,et al.  Inhibition of Cell Migration by Abl Family Tyrosine Kinases through Uncoupling of Crk-CAS Complexes* , 2001, The Journal of Biological Chemistry.

[21]  A. Chalmers,et al.  Crk family adaptor proteins trans‐activate c‐Abl kinase , 2001, Genes to cells : devoted to molecular & cellular mechanisms.

[22]  D. Kufe,et al.  The ARG Tyrosine Kinase Interacts with Siva-1 in the Apoptotic Response to Oxidative Stress* , 2001, The Journal of Biological Chemistry.

[23]  P. Zipfel,et al.  Functional interaction between c-Abl and the p21-activated protein kinase gamma-PAK. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[24]  P. Zipfel,et al.  The c-Abl Tyrosine Kinase Is Regulated Downstream of the B Cell Antigen Receptor and Interacts with CD191 , 2000, The Journal of Immunology.

[25]  S. Goff,et al.  Cytoskeletal protein PSTPIP1 directs the PEST-type protein tyrosine phosphatase to the c-Abl kinase to mediate Abl dephosphorylation. , 2000, Molecular cell.

[26]  R. V. van Etten,et al.  c-Abl Has High Intrinsic Tyrosine Kinase Activity That Is Stimulated by Mutation of the Src Homology 3 Domain and by Autophosphorylation at Two Distinct Regulatory Tyrosines* , 2000, The Journal of Biological Chemistry.

[27]  S. Goff,et al.  Abl Interactor 1 Binds to Sos and Inhibits Epidermal Growth Factor- and v-Abl-Induced Activation of Extracellular Signal-Regulated Kinases , 2000, Molecular and Cellular Biology.

[28]  P. Seeburg,et al.  Structural mechanism for STI-571 inhibition of abelson tyrosine kinase. , 2000, Science.

[29]  A. VanDongen,et al.  Localization and Phosphorylation of Abl-Interactor Proteins, Abi-1 and Abi-2, in the Developing Nervous System , 2000, Molecular and Cellular Neuroscience.

[30]  L. Langeberg,et al.  Scar/WAVE‐1, a Wiskott–Aldrich syndrome protein, assembles an actin‐associated multi‐kinase scaffold , 2000, The EMBO journal.

[31]  M. Fujimoto,et al.  CD19 regulates Src family protein tyrosine kinase activation in B lymphocytes through processive amplification. , 2000, Immunity.

[32]  M. Schwartz,et al.  The c-Abl tyrosine kinase contributes to the transient activation of MAP kinase in cells plated on fibronectin , 2000, Oncogene.

[33]  R. Weichselbaum,et al.  Activation of the Cytoplasmic c-Abl Tyrosine Kinase by Reactive Oxygen Species* , 2000, The Journal of Biological Chemistry.

[34]  C. Goodman,et al.  Repulsive Axon Guidance Abelson and Enabled Play Opposing Roles Downstream of the Roundabout Receptor , 2000, Cell.

[35]  L. Tsai,et al.  Cables Links Cdk5 and c-Abl and Facilitates Cdk5 Tyrosine Phosphorylation, Kinase Upregulation, and Neurite Outgrowth , 2000, Neuron.

[36]  L. Tsai,et al.  Neurotoxicity induces cleavage of p35 to p25 by calpain , 2000, Nature.

[37]  T. Curran,et al.  Cortical development: Cdk5 gets into sticky situations , 2000, Current Biology.

[38]  B. Dickson,et al.  Trio Combines with Dock to Regulate Pak Activity during Photoreceptor Axon Pathfinding in Drosophila , 2000, Cell.

[39]  D. Monaghan,et al.  Interaction of the N-Methyl-d-Aspartic Acid Receptor NR2D Subunit with the c-Abl Tyrosine Kinase* , 2000, The Journal of Biological Chemistry.

[40]  Huidy Shu,et al.  The Guanine Nucleotide Exchange Factor Trio Mediates Axonal Development in the Drosophila Embryo , 2000, Neuron.

[41]  David J. Forsthoefel,et al.  Dosage-Sensitive, Reciprocal Genetic Interactions between the Abl Tyrosine Kinase and the Putative GEF trio Reveal trio's Role in Axon Pathfinding , 2000, Neuron.

[42]  D. Kufe,et al.  Interaction between Protein Kinase C δ and the c-Abl Tyrosine Kinase in the Cellular Response to Oxidative Stress* , 2000, The Journal of Biological Chemistry.

[43]  Lorene M Lanier,et al.  From Abl to actin: Abl tyrosine kinase and associated proteins in growth cone motility , 2000, Current Opinion in Neurobiology.

[44]  Elaine Fuchs,et al.  Directed Actin Polymerization Is the Driving Force for Epithelial Cell–Cell Adhesion , 2000, Cell.

[45]  G. Superti-Furga,et al.  A nuclear tyrosine phosphorylation circuit: c‐Jun as an activator and substrate of c‐Abl and JNK , 2000, The EMBO journal.

[46]  A. Shinohara,et al.  c-Abl Tyrosine Kinase Is Not Essential for Ataxia Telangiectasia Mutated Functions in Chromosomal Maintenance* , 2000, The Journal of Biological Chemistry.

[47]  L. Tsai,et al.  Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration , 1999, Nature.

[48]  S. Goff,et al.  c-Abl-induced apoptosis, but not cell cycle arrest, requires mitogen-activated protein kinase kinase 6 activation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[49]  T. Curran,et al.  Mutant mice with scrambled brains: understanding the signaling pathways that control cell positioning in the CNS. , 1999, Genes & development.

[50]  B. Mayer,et al.  Activation of the Abl Tyrosine Kinase in Vivo by Src Homology 3 Domains from the Src Homology 2/Src Homology 3 Adaptor Nck* , 1999, The Journal of Biological Chemistry.

[51]  C. Betsholtz,et al.  EPS8 and E3B1 transduce signals from Ras to Rac , 1999, Nature.

[52]  Hoffman Fm,et al.  Drosophila abelson interacting protein (dAbi) is a positive regulator of abelson tyrosine kinase activity. , 1999 .

[53]  A. Kazlauskas,et al.  c-Abl is activated by growth factors and Src family kinases and has a role in the cellular response to PDGF. , 1999, Genes & development.

[54]  S. Bagrodia,et al.  Pak to the future. , 1999, Trends in cell biology.

[55]  Stevan R. Hubbard,et al.  Src autoinhibition: let us count the ways , 1999, Nature Structural Biology.

[56]  S. Zipursky,et al.  Pak Functions Downstream of Dock to Regulate Photoreceptor Axon Guidance in Drosophila , 1999, Cell.

[57]  Reuven Agami,et al.  Interaction of c-Abl and p73α and their collaboration to induce apoptosis , 1999, Nature.

[58]  Jijie Gu,et al.  p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage , 1999, Nature.

[59]  Antonio Costanzo,et al.  The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage , 1999, Nature.

[60]  S. Harrison,et al.  Crystal structures of c-Src reveal features of its autoinhibitory mechanism. , 1999, Molecular cell.

[61]  R. A. Etten.  Cycling, stressed-out and nervous: cellular functions of c-Abl , 1999 .

[62]  D. Baltimore,et al.  Radiation-induced Assembly of Rad51 and Rad52 Recombination Complex Requires ATM and c-Abl* , 1999, The Journal of Biological Chemistry.

[63]  C. Goodman,et al.  Slit Is the Midline Repellent for the Robo Receptor in Drosophila , 1999, Cell.

[64]  David Van Vactor,et al.  The Tyrosine Kinase Abl and Its Substrate Enabled Collaborate with the Receptor Phosphatase Dlar to Control Motor Axon Guidance , 1999, Neuron.

[65]  C. Goodman,et al.  Profilin and the Abl Tyrosine Kinase Are Required for Motor Axon Outgrowth in the Drosophila Embryo , 1999, Neuron.

[66]  J. Borg,et al.  Interaction of Cytosolic Adaptor Proteins with Neuronal Apolipoprotein E Receptors and the Amyloid Precursor Protein* , 1998, The Journal of Biological Chemistry.

[67]  D. Baltimore,et al.  Essential Roles for the Abl and Arg Tyrosine Kinases in Neurulation , 1998, Neuron.

[68]  L. Tsai,et al.  The p35/Cdk5 kinase is a neuron-specific Rac effector that inhibits Pak1 activity , 1998, Nature.

[69]  D. McDonald,et al.  Nuclear-cytoplasmic shuttling of C-ABL tyrosine kinase. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[70]  M. Schwartz,et al.  Integrins Regulate the Association and Phosphorylation of Paxillin by c-Abl* , 1998, The Journal of Biological Chemistry.

[71]  M. Peifer,et al.  Roles of Armadillo, a Drosophila catenin, during central nervous system development , 1998, Current Biology.

[72]  D. Cortez,et al.  Oncogenic Abl and Src tyrosine kinases elicit the ubiquitin-dependent degradation of target proteins through a Ras-independent pathway. , 1998, Genes & development.

[73]  J. Morgan,et al.  Requirement for Atm in ionizing radiation-induced cell death in the developing central nervous system. , 1998, Science.

[74]  C. Bailly,et al.  The DNA binding domain of the human c-Abl tyrosine kinase preferentially binds to DNA sequences containing an AAC motif and to distorted DNA structures. , 1998, Biochemistry.

[75]  G. Superti-Furga,et al.  An intramolecular SH3-domain interaction regulates c-Abl activity , 1998, Nature Genetics.

[76]  K. Vuori,et al.  CAS/Crk Coupling Serves as a “Molecular Switch” for Induction of Cell Migration , 1998, The Journal of cell biology.

[77]  P. Sung,et al.  Regulation of Rad51 Function by c-Abl in Response to DNA Damage* , 1998, The Journal of Biological Chemistry.

[78]  G. Bokoch,et al.  Membrane targeting of p21‐activated kinase 1 (PAK1) induces neurite outgrowth from PC12 cells , 1998, The EMBO journal.

[79]  Marc Tessier-Lavigne,et al.  Roundabout Controls Axon Crossing of the CNS Midline and Defines a Novel Subfamily of Evolutionarily Conserved Guidance Receptors , 1998, Cell.

[80]  A. Pendergast,et al.  The amphiphysin-like protein 1 (ALP1) interacts functionally with the cABL tyrosine kinase and may play a role in cytoskeletal regulation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[81]  T. Cotter,et al.  Abl expression in human fetal and adult tissues, tumours and tumour microvessels , 1997, The Journal of pathology.

[82]  Y Nishizuka,et al.  Activation of protein kinase C by tyrosine phosphorylation in response to H2O2. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[83]  R. V. van Etten,et al.  The PAG gene product, a stress-induced protein with antioxidant properties, is an Abl SH3-binding protein and a physiological inhibitor of c-Abl tyrosine kinase activity. , 1997, Genes & development.

[84]  W. Kaelin,et al.  p73 is a human p53-related protein that can induce apoptosis , 1997, Nature.

[85]  W. Pear,et al.  BCR/ABL induces multiple abnormalities of cytoskeletal function. , 1997, The Journal of clinical investigation.

[86]  D. Baltimore,et al.  Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation , 1997, Nature.

[87]  Y. Shiloh,et al.  Interaction between ATM protein and c-Abl in response to DNA damage , 1997, Nature.

[88]  S. Inoue,et al.  Functional interaction between DNA-PK and c-Abl in response to DNA damage , 1997, Nature.

[89]  R. Weichselbaum,et al.  Regulation of DNA damage-induced apoptosis by the c-Abl tyrosine kinase. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[90]  John Kuriyan,et al.  Crystal structure of the Src family tyrosine kinase Hck , 1997, Nature.

[91]  Michael J. Eck,et al.  Three-dimensional structure of the tyrosine kinase c-Src , 1997, Nature.

[92]  M. Schwartz,et al.  Integrin regulation of c-Abl tyrosine kinase activity and cytoplasmic-nuclear transport. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[93]  S. K. Shore,et al.  c-ABL tyrosine kinase activity is regulated by association with a novel SH3-domain-binding protein , 1996, Molecular and cellular biology.

[94]  M. Karin,et al.  Three distinct signalling responses by murine fibroblasts to genotoxic stress , 1996, Nature.

[95]  C. Goodman,et al.  The Molecular Biology of Axon Guidance , 1996, Science.

[96]  S. Goff,et al.  Increased sensitivity to apoptotic stimuli in c-abl-deficient progenitor B-cell lines. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[97]  J. Melo,et al.  The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype. , 1996, Blood.

[98]  A. Ullrich,et al.  Dephosphorylation of receptor tyrosine kinases as target of regulation by radiation, oxidants or alkylating agents. , 1996, The EMBO journal.

[99]  R. Weichselbaum,et al.  Activation of p38 Mitogen-activated Protein Kinase by c-Abl-dependent and -independent Mechanisms* , 1996, The Journal of Biological Chemistry.

[100]  Jean Y. J. Wang,et al.  Binding of A/T-rich DNA by Three High Mobility Group-like Domains in c-Abl Tyrosine Kinase* , 1996, The Journal of Biological Chemistry.

[101]  S. Chung,et al.  Isoform-specific functions of c-abl: type I is necessary for differentiation, and type IV is inhibitory to apoptosis. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[102]  F. Alt,et al.  Abnormal peripheral lymphocyte function in c-abl mutant mice. , 1996, Cellular immunology.

[103]  R. Weichselbaum,et al.  Role for c-Abl tyrosine kinase in growth arrest response to DNA damage , 1996, Nature.

[104]  G. Kruh,et al.  Subcellular localization of the Arg protein tyrosine kinase. , 1996, Oncogene.

[105]  D. Krainc,et al.  Identification of ArgBP1, an Arg protein tyrosine kinase binding protein that is the human homologue of a CNS-specific Xenopus gene. , 1996, Oncogene.

[106]  G. Superti-Furga,et al.  Analysis of human c-Abl tyrosine kinase activity and regulation in S. pombe. , 1996, Oncogene.

[107]  R. V. van Etten,et al.  The cytostatic function of c‐Abl is controlled by multiple nuclear localization signals and requires the p53 and Rb tumor suppressor gene products. , 1996, The EMBO journal.

[108]  L. Tsai,et al.  The cdk5/p35 kinase is essential for neurite outgrowth during neuronal differentiation. , 1996, Genes & development.

[109]  L. Zon,et al.  c-Abl Activation Regulates Induction of the SEK1/Stress-activated Protein Kinase Pathway in the Cellular Response to 1-β-D-Arabinofuranosylcytosine (*) , 1995, The Journal of Biological Chemistry.

[110]  A. Pendergast,et al.  Abi-2, a novel SH3-containing protein interacts with the c-Abl tyrosine kinase and modulates c-Abl transforming activity. , 1995, Genes & development.

[111]  S. Goff,et al.  Abl-interactor-1, a novel SH3 protein binding to the carboxy-terminal portion of the Abl protein, suppresses v-abl transforming activity. , 1995, Genes & development.

[112]  G Mazzini,et al.  Oligodeoxynucleotides antisense to c-abl specifically inhibit entry into S-phase of CD34+ hematopoietic cells and their differentiation to granulocyte-macrophage progenitors. , 1995, Blood.

[113]  P. J. Welch,et al.  Abrogation of retinoblastoma protein function by c-Abl through tyrosine kinase-dependent and -independent mechanisms , 1995, Molecular and cellular biology.

[114]  S. Lo,et al.  Increased tyrosine phosphorylation of focal adhesion proteins in myeloid cell lines expressing p210BCR/ABL. , 1995, Oncogene.

[115]  R. Weichselbaum,et al.  Activation of the c-Abl tyrosine kinase in the stress response to DMA-damaging agents , 1995, Nature.

[116]  T. Hambuch,et al.  p53 dependent growth suppression by the c-Abl nuclear tyrosine kinase. , 1995, Oncogene.

[117]  B. Koller,et al.  Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. , 1995, Immunity.

[118]  R. V. van Etten,et al.  Introduction of a loss-of-function point mutation from the SH3 region of the Caenorhabditis elegans sem-5 gene activates the transforming ability of c-abl in vivo and abolishes binding of proline-rich ligands in vitro. , 1995, Oncogene.

[119]  S. Chung,et al.  Deregulation of c-abl mediated cell growth after retroviral transfer and expression of antisense sequences. , 1995, Oncogene.

[120]  D. Baltimore,et al.  Proline-rich sequences that bind to Src homology 3 domains with individual specificities. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[121]  D. Ward,et al.  Nuclear foci of mammalian Rad51 recombination protein in somatic cells after DNA damage and its localization in synaptonemal complexes. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[122]  J. Juang,et al.  enabled, a dosage-sensitive suppressor of mutations in the Drosophila Abl tyrosine kinase, encodes an Abl substrate with SH3 domain-binding properties. , 1995, Genes & development.

[123]  Charis Eng,et al.  Catalytic specificity of protein-tyrosine kinases is critical for selective signalling , 1995, Nature.

[124]  S. Hubbard,et al.  Crystal structure of the tyrosine kinase domain of the human insulin receptor , 1994, Nature.

[125]  R. Rickles,et al.  Identification of Src, Fyn, Lyn, PI3K and Abl SH3 domain ligands using phage display libraries. , 1994, The EMBO journal.

[126]  D. Baltimore,et al.  Mutagenic analysis of the roles of SH2 and SH3 domains in regulation of the Abl tyrosine kinase , 1994, Molecular and cellular biology.

[127]  C. Sawyers,et al.  The nuclear tyrosine kinase c-abl negatively regulates cell growth , 1994, Cell.

[128]  D. Baltimore,et al.  Abl protein-tyrosine kinase selects the Crk adapter as a substrate using SH3-binding sites. , 1994, Genes & development.

[129]  M. Resh,et al.  Myristylation and palmitylation of Src family members: The fats of the matter , 1994, Cell.

[130]  P. Janmey,et al.  The COOH terminus of the c-Abl tyrosine kinase contains distinct F- and G-actin binding domains with bundling activity [published erratum appears in J Cell Biol 1994 Mar;124(5):865] , 1994, The Journal of cell biology.

[131]  J. Wang,et al.  Tyrosine phosphorylation of mammalian RNA polymerase II carboxyl-terminal domain. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[132]  J. Wang,et al.  A coiled-coil oligomerization domain of Bcr is essential for the transforming function of Bcr-Abl oncoproteins , 1993, Molecular and cellular biology.

[133]  P. J. Welch,et al.  A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle , 1993, Cell.

[134]  R. Kurzrock,et al.  Subcellular localization of Bcr, Abl, and Bcr-Abl proteins in normal and leukemic cells and correlation of expression with myeloid differentiation. , 1993, The Journal of clinical investigation.

[135]  N. Rosenberg,et al.  Oncogenic activation of c-ABL by mutation within its last exon , 1993, Molecular and cellular biology.

[136]  J. Wang,et al.  An actin‐binding function contributes to transformation by the Bcr‐Abl oncoprotein of Philadelphia chromosome‐positive human leukemias. , 1993, The EMBO journal.

[137]  T. Pawson,et al.  SH2 domains recognize specific phosphopeptide sequences , 1993, Cell.

[138]  F. Hoffmann,et al.  Dosage-sensitive modifiers of Drosophila abl tyrosine kinase function: prospero, a regulator of axonal outgrowth, and disabled, a novel tyrosine kinase substrate. , 1993, Genes & development.

[139]  P Cicchetti,et al.  Identification of a ten-amino acid proline-rich SH3 binding site. , 1993, Science.

[140]  F. Hoffmann,et al.  Increased levels of the Drosophila Abelson tyrosine kinase in nerves and muscles: subcellular localization and mutant phenotypes imply a role in cell-cell interactions. , 1992, Development.

[141]  D. Baltimore,et al.  Identification of a protein that binds to the SH3 region of Abl and is similar to Bcr and GAP-rho. , 1992, Science.

[142]  Jean Y. J. Wang,et al.  Cell Cycle—Regulated Binding of c-Abl Tyrosine Kinase to DNA , 1992, Science.

[143]  G. Kruh,et al.  Arg encodes a widely expressed 145 kDa protein-tyrosine kinase. , 1991, Oncogene.

[144]  F. McCormick,et al.  Evidence for regulation of the human ABL tyrosine kinase by a cellular inhibitor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[145]  R. Bronson,et al.  Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene , 1991, Cell.

[146]  S. Goff,et al.  Mice homozygous for the abl m1 mutation show poor viability and depletion of selected B and T cell populations , 1991, Cell.

[147]  O. Witte,et al.  BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias , 1991, Molecular and cellular biology.

[148]  J. Wang,et al.  Activation of tyrosinase kinase and microfilament-binding functions of c-abl by bcr sequences in bcr/abl fusion proteins , 1991, Molecular and cellular biology.

[149]  S. Aaronson,et al.  The complete coding sequence of arg defines the Abelson subfamily of cytoplasmic tyrosine kinases. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[150]  F. Hoffmann,et al.  Genetic suppression of mutations in the Drosophila abl proto-oncogene homolog. , 1990, Science.

[151]  C. Goodman,et al.  Genetic analysis of a drosophila neural cell adhesion molecule: Interaction of fasciclin I and abelson tyrosine kinase mutations , 1990, Cell.

[152]  Y. Zick,et al.  The insulinomimetic agents H2O2 and vanadate stimulate protein tyrosine phosphorylation in intact cells. , 1990, The Journal of biological chemistry.

[153]  D. Baltimore,et al.  The mouse type IV c-abl gene product is a nuclear protein, and activation of transforming ability is associated with cytoplasmic localization , 1989, Cell.

[154]  F. Gertler,et al.  Drosophila abl tyrosine kinase in embryonic CNS axons: A role in axonogenesis is revealed through dosage-sensitive interactions with disabled , 1989, Cell.

[155]  D. Baltimore,et al.  N‐terminal mutations activate the leukemogenic potential of the myristoylated form of c‐abl. , 1989, The EMBO journal.

[156]  J. Wang,et al.  Deletion of an N‐terminal regulatory domain of the c‐abl tyrosine kinase activates its oncogenic potential. , 1989, The EMBO journal.

[157]  J. Wang,et al.  Differential expression of type-specific c-abl mRNAs in mouse tissues and cell lines , 1988, Molecular and cellular biology.

[158]  F. Hoffmann,et al.  DNA sequence, structure, and tyrosine kinase activity of the Drosophila melanogaster Abelson proto-oncogene homolog , 1988, Molecular and cellular biology.

[159]  F. Hoffmann,et al.  The Drosophila abelson proto-oncogene homolog: Identification of mutant alleles that have pleiotropic effects late in development , 1987, Cell.

[160]  Bruce A. Roe,et al.  Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene , 1986, Cell.

[161]  M. Capecchi,et al.  Isolation and characterization of Caenorhabditis elegans DNA sequences homologous to the v-abl oncogene. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[162]  G. Daley,et al.  Alternative 5′ exons in c-abl mRNA , 1986, Cell.

[163]  O. Witte,et al.  Detection of c-abl tyrosine kinase activity in vitro permits direct comparison of normal and altered abl gene products , 1985, Molecular and cellular biology.

[164]  Susan M. Watanabe,et al.  An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity , 1984, Cell.

[165]  Rosalind C. Lee,et al.  The mouse c-abl locus: Molecular cloning and characterization , 1984, Cell.

[166]  J. Stephenson,et al.  Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22 , 1984, Cell.

[167]  B. Shilo,et al.  Nucleotide sequences of the drosophila src and abl homologs: conservation and variability in the src family oncogenes , 1983, Cell.

[168]  J. Stephenson,et al.  Localization of the c-abl oncogene adjacent to a translocation break point in chronic myelocytic leukaemia , 1983, Nature.

[169]  I. Verma,et al.  Differential expression of cellular oncogenes during pre- and postnatal development of the mouse , 1982, Nature.

[170]  D. Baltimore,et al.  Structure of the Abelson murine leukemia virus genome and the homologous cellular gene: Studies with cloned viral DNA , 1980, Cell.

[171]  T D Pollard,et al.  Regulation of actin filament network formation through ARP2/3 complex: activation by a diverse array of proteins. , 2001, Annual review of biochemistry.

[172]  A. Gavin,et al.  Regulation of Human c-Abl Tyrosine Kinase Activity in Xenopus Oocytes and Acceleration of Progesterone-Induced G2/M Transition by Oncogenic Forms , 1999, Biological chemistry.

[173]  Y. Shiloh,et al.  The genetic defect in ataxia-telangiectasia. , 1997, Annual review of immunology.